Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126351821 | 12635182 | 1 | I | 20160727 | 20160808 | 20160808 | EXP | AU-MUNDIPHARMA DS AND PHARMACOVIGILANCE-GBR-2016-0039412 | PURDUE | 0.00 | F | Y | 102.00000 | KG | 20160802 | MD | AU | AU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126351821 | 12635182 | 1 | PS | NORSPAN | BUPRENORPHINE | 1 | Transdermal | 10 MCG, Q1H | U | U | 21306 | 10 | UG | TRANSDERMAL PATCH | |||||
| 126351821 | 12635182 | 2 | SS | NUVIGIL | ARMODAFINIL | 1 | Oral | 250 MG, DAILY | N | U | 0 | 250 | MG | ||||||
| 126351821 | 12635182 | 3 | SS | ENDONE | OXYCODONE HYDROCHLORIDE | 1 | Oral | UNK | U | U | 0 | ||||||||
| 126351821 | 12635182 | 4 | C | ABILIFY | ARIPIPRAZOLE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 5 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 6 | C | BRICANYL | TERBUTALINE SULFATE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 7 | C | FRUSEMIDE /00032601/ | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 8 | C | IMOVANE | ZOPICLONE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 9 | C | MAXALT | RIZATRIPTAN BENZOATE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 10 | C | MELATONIN | MELATONIN | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 11 | C | MOGADON | NITRAZEPAM | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 12 | C | MOTILIUM | DOMPERIDONE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 13 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 14 | C | OXYTROL | OXYBUTYNIN | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 15 | C | SERETIDE | FLUTICASONE PROPIONATESALMETEROL XINAFOATE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 16 | C | SLOW-K | POTASSIUM CHLORIDE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 17 | C | THYROXINE | LEVOTHYROXINE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 18 | C | TOPAMAX | TOPIRAMATE | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 19 | C | VALIUM | DIAZEPAM | 1 | U | 0 | |||||||||||
| 126351821 | 12635182 | 20 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126351821 | 12635182 | 1 | Product used for unknown indication |
| 126351821 | 12635182 | 2 | Product used for unknown indication |
| 126351821 | 12635182 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126351821 | 12635182 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126351821 | 12635182 | Anxiety | |
| 126351821 | 12635182 | Dizziness | |
| 126351821 | 12635182 | Drug ineffective | |
| 126351821 | 12635182 | Psychomotor hyperactivity | |
| 126351821 | 12635182 | Somnambulism |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126351821 | 12635182 | 2 | 20160504 | 20160530 | 0 |